Filtered By:
Specialty: Cardiology
Procedure: Coronary Artery Bypass Graft

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 758 results found since Jan 2013.

Prognostic Value of Procalcitonin for Morbidity and Mortality in Patients after Cardiac Surgery
CONCLUSION: Higher PCT serum levels in CABG patients are associated with the increased early mortality rate, sternum wound infection, and PC transfusion. Additionally, the other factors associated with mortality in the patients under study included dyslipidemia and hypertension.PMID:34350035 | PMC:PMC8328725 | DOI:10.1155/2021/1542551
Source: Cardiology Research and Practice - August 5, 2021 Category: Cardiology Authors: Ahmad Amouzeshi Farshid Abedi Mahmoud Zardast Yaser Rezaeian Bilondi Zahra Amouzeshi Source Type: research

Perioperative safety of simultaneous off-pump coronary artery bypass grafting with non-cardiac surgery of moderate-to-severe severity
Background To evaluate the perioperative safety of simultaneous off-pump coronary artery bypass grafting (OPCABG) with non-cardiac surgery. Methods From September 2013 to January 2019, patients who underwent OPCABG surgery in the Department of Cardiology, Peking University First Hospital were included in this retrospective study. A total of 54 patients who underwent simultaneous surgery were defined as simultaneous surgery group. A total of 108 patients who had recently undergone isolated OPCABG surgery, and had similar vascular reconstruction methods were selected for matching, and these patients were defined a...
Source: Coronary Artery Disease - July 27, 2021 Category: Cardiology Tags: CABG Source Type: research

Pericardial SCUBE1 levels may help predict postoperative results in patients operated on for coronary artery bypass graft surgery
CONCLUSIONS: High levels of pericardial SCUBE1 may help us predict the need for postoperative intra-aortic balloon pump support and the need for temporary cardiac pacing, however they were not helpful in predicting prolonged intensive care unit stay and early postoperative mortality.PMID:34292290 | DOI:10.5830/CVJA-2021-020
Source: Cardiovascular Journal of Africa - July 22, 2021 Category: Cardiology Authors: Taha Özkara Volkan Y üksel Orkut G üçlü Serhat H üseyin Eray Özgün Fatma Nesrin Turan Suat Canbaz Source Type: research

Ticagrelor: clinical development and future potential
Rev Cardiovasc Med. 2021 Jun 30;22(2):373-394. doi: 10.31083/j.rcm2202044.ABSTRACTPlatelets participate centrally in atherothrombosis, resulting in vessel occlusion and ischaemia. Consequently, optimisation of antiplatelet regimens has the potential to further reduce the residual burden of morbidity and mortality associated with atherosclerosis. Ticagrelor is a potent oral platelet P2Y12 receptor antagonist that (1) inhibits a central amplification pathway of platelet activation directly as well as via an active metabolite, (2) has a rapid onset and offset of antiplatelet action that remains consistent in the circulation d...
Source: Reviews in Cardiovascular Medicine - July 14, 2021 Category: Cardiology Authors: Nicholas C Sanderson William A E Parker Robert F Storey Source Type: research